The killing of Charlie Kirk is a stark reminder that the kids aren’t alright, and young men in particular need our attention. Here’s how to check on your teen boy, writes @JulieJargon.

Health Secretary Robert F. Kennedy Jr. recently convened his selected vaccine advisers at the CDC, where they expressed a desire to reevaluate vaccine recommendations and focus more on potential side effects. This meeting is significant as it could lead to changes in public health policy and how vaccines are assessed, reflecting a shift in the ongoing conversation about vaccine safety and efficacy.

The recent decision by Kennedy's vaccine panel to limit access to COVID shots has raised significant concerns among public health advocates. This move could hinder efforts to achieve widespread immunity and protect vulnerable populations, especially as new variants emerge. It's crucial to understand the implications of such restrictions on public health and the ongoing fight against the pandemic.

Recent research and expanded diagnostic criteria are reshaping our understanding of autism, with experts firmly stating that there is no connection between vaccines and the condition. A significant review by HHS Secretary Robert F. Kennedy is anticipated soon, which could further clarify misconceptions and enhance public awareness. This matters because it helps to dispel myths surrounding autism, promotes informed discussions, and supports families affected by the condition.

A key panel from the CDC has voted to shift its recommendations regarding COVID vaccines, suggesting that the decision to get vaccinated should be left to individuals rather than being a blanket recommendation for all adults. This change could significantly impact insurance coverage and access to vaccines, making it a crucial development in public health policy.

The FDA has approved Merck's new injected version of Keytruda, a significant cancer treatment. While this innovation promises quicker and easier administration, it raises concerns about potentially slowing the adoption of more affordable alternatives, which could lead to increased healthcare costs by billions. This development is crucial as it highlights the ongoing tension between innovation and accessibility in cancer care.

New medical guidelines strongly advise against the use of cannabis during pregnancy, highlighting its association with poor birth outcomes and developmental delays in children. This is particularly concerning given that studies show a significant percentage of pregnant women, especially those aged 19 to 22, are using marijuana. Understanding these risks is crucial for expectant mothers to ensure the health and well-being of their children.